Acquisition by David Novack of 20000 shares of Dynavax Technologies at 5.42 subject to Rule 16b-3
| DVAX Stock | USD 12.91 0.25 1.97% |
Slightly above 70 percent of all Dynavax Technologies' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Dynavax Technologies suggests that a large number of traders are confidant. Dynavax Technologies' investing sentiment can be driven by a variety of factors including economic data, Dynavax Technologies' earnings reports, geopolitical events, and overall market trends.
Dynavax |
Filed transaction by Dynavax Technologies Officer: President & Coo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Dynavax Technologies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Dynavax Technologies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Dynavax Technologies Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dynavax Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dynavax Technologies Fundamental Analysis
We analyze Dynavax Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Dynavax Technologies is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Dynavax Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dynavax Technologies stock to make a market-neutral strategy. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics with similar companies.
Peers
Dynavax Technologies Related Equities
| AQST | Aquestive Therapeutics | 5.74 | ||||
| IRWD | Ironwood Pharmaceuticals | 4.26 | ||||
| ANIP | ANI Pharmaceuticals | 2.64 | ||||
| AMPH | Amphastar | 2.24 | ||||
| LNTH | Lantheus Holdings | 0.83 | ||||
| EBS | Emergent Biosolutions | 0.80 | ||||
| ALKS | Alkermes Plc | 0.24 | ||||
| ITCI | Intracellular | 0.19 | ||||
| PCRX | Pacira BioSciences, | 0.83 | ||||
| NBIX | Neurocrine Biosciences | 1.03 | ||||
| COLL | Collegium Pharmaceutical | 1.54 | ||||
| DRRX | Durect | 3.19 |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.